Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-011848
Filing Date
2016-01-15
Accepted
2016-01-15 18:13:56
Documents
1
Period of Report
2016-01-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4144
  Complete submission text file 0000899243-16-011848.txt   5673
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address EP TAYLOR DRIVE, LYFORD CAY NEW PROVIDENCE C5 N7776
Business Address 303 SHIRLEY STREET P.O. BOX N-492 NASSAU C5 00000 407-909-9970
Braslyn Ltd. (Reporting) CIK: 0001642355 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 161346587